QUAM PLUS FIN (00952): Lin Huaihan resigns as executive director.
Hua Fu Jianye Finance (00952) issued an announcement that Mr. Lin Huaihan intends to invest more time in personal affairs and other businesses...
QUAM PLUS FIN (00952) announced that Mr. Lam Wai Hon has resigned as an executive director of the company, as he wishes to devote more time to personal matters and other business endeavors. He will also no longer serve as a member of the company's executive committee, effective from January 16, 2025. After resigning as an executive director, Mr. Lam will continue to serve as a business partner of the company.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
